The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BioAtla, Inc(NASDAQ:BCAB)


BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small c...
Share this website to your friends
BioAtla Days Payable Outstanding ttm (DPO)
BioAtla Op Cashflow Per Share ttm
BioAtla Free Cashflow Per Share ttm
BioAtla Cash Per Share ttm
BioAtla P/S ratio ttm
BioAtla (GAAP) P/E ratio ttm
BioAtla P/B ratio ttm
No extra charts and metrics for this ticker.